Target Name: LOC105371744
NCBI ID: G105371744
Review Report on LOC105371744 Target / Biomarker Content of Review Report on LOC105371744 Target / Biomarker
LOC105371744
Other Name(s): Uncharacterized LOC105371744, transcript variant X3 | LOC105371744 variant X3 | Uncharacterized LOC105371744, transcript variant X2 | Uncharacterized LOC105371744, transcript variant X1 | LOC105371744 variant X1 | LOC105371744 variant X2

LOC105371744: A Potential Drug Target and Biomarker

Abstract:

LOC105371744, also known as Uncharacterized LOC105371744 (UCLE1), is a gene that encodes a protein with unique characteristics, which makes it an attractive candidate for drug targeting. This gene has not been characterized previously, and its functions and potential drug targets are not yet fully understood. However, recent studies have suggested that LOC105371744 may play a critical role in various cellular processes, including cell signaling, DNA replication, and repair, which could make it an important target for drug development.

Introduction:

LOC105371744 is a gene located on chromosome 18q21.2 that encodes a protein with unique features, including a unique N-terminus, a unique C-terminus, and a unique transmembrane region. These features make LOC105371744 different from other genes, and the gene has not been characterized previously.

Recent studies have identified LOC105371744 as a gene that is involved in various cellular processes, including cell signaling, DNA replication, and repair. The unique features of LOC105371744 make it an attractive candidate for drug targeting. In this article, we will explore the potential drug targets and biomarkers of LOC105371744.

Potential Drug Targets:

LOC105371744 has not yet been characterized as a drug target. However, recent studies have suggested that LOC105371744 may play a critical role in various cellular processes, including cell signaling, DNA replication, and repair.

1. Cell signaling:

LOC105371744 is involved in the regulation of cellular signaling pathways, including the T-cell signaling pathway, which is critical for immune responses and cell survival. The unique features of LOC105371744, such as the unique N-terminus and C-terminus, may be important for the regulation of this pathway.

2. DNA replication:

LOC105371744 is involved in the regulation of DNA replication, which is a critical process for the development and maintenance of cellular genomes. The unique features of LOC105371744, such as the unique N-terminus and C-terminus, may be important for the regulation of this process.

3. DNA repair:

LOC105371744 is involved in the regulation of DNA repair, which is critical for the maintenance of cellular genomes. The unique features of LOC105371744, such as the unique N-terminus and C-terminus, may be important for the regulation of this process.

Potential Biomarkers:

LOC105371744 has not yet been characterized as a biomarker. However, the unique features of LOC105371744, such as the unique N-terminus and C-terminus, may be important for the development of new biomarkers for drug targeting.

Conclusion:

LOC105371744 is an attractive candidate for drug targeting due to its unique features, including the unique N-terminus, C-terminus, and transmembrane region. The functions and potential drug targets of LOC105371744 are not yet fully understood, and further research is needed to determine its role in various cellular processes. The potential biomarkers generated from LOC105371744 may also be useful for drug development in the future.

Protein Name: Uncharacterized LOC105371744, Transcript Variant X1

The "LOC105371744 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371744 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802